The complexity of serotype replacement of pneumococci

References

• WHO Publications. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper – February 2019. Weekly Epidemiological Report, 2019;94:85–104. http://www.who.int/wer
   Google Scholar
• WHO Publication. Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000–2012. MMWR Morb Mortal Wkly Rep. 2013;62:308–11.
   PubMed Web of Science ®Google Scholar
• available online [accessed 2019 Mar 15]: http://www.cdc.gov/pneumococcal/surveillance.html
   Google Scholar
• Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, Petit S, Zansky SM, Harrison LH, Reingold A, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015 Mar;15(3):301–09. doi:10.1016/S1473-3099(14)71081-3.
   PubMed Web of Science ®Google Scholar
• Berical AC, Harris D, Dela Cruz CS, Possick JD. Pneumococcal vaccination strategies. An update and perspective. Ann Am Thorac Soc. 2016;13(6):933–44. doi:10.1513/AnnalsATS.201511-778FR.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe, 2011. Stockholm, Sweden: ECDC; 2013.
   Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe, 2012. Stockholm, Sweden: ECDC; 2015.
   Google Scholar
• European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 – Invasive pneumococcal disease. [Internet]. Stockholm, Sweden: ECDC; 2016 [accessed 2019 Mar 19]. http://ecdc.europa.eu/en/healthtopics/invasivepneumococcaldisease/Pages/Annualepidemiologicalreport2016.aspx.
   Google Scholar
• European Centre for Disease Prevention and Control. Annual epidemiological report 2014 – Vaccine-preventable diseases – invasive bacterial diseases. Stockholm, Sweden: ECDC; 2015.
   Google Scholar
• European Centre for Disease Prevention and Control. Invasive pneumococcal disease. In: ECDC. Annual epidemiological report for 2015. Stockholm, Sweden: ECDC; 2017.
   Google Scholar
• European Centre for Disease Prevention and Control. Invasive pneumococcal disease. In: ECDC. Annual epidemiological report for 2016. Stockholm, Sweden: ECDC; 2018.
   Google Scholar
• Tóthpál A, Laub K, Kardos S, Tirczka T, Kocsis A, van der Linden M, Dobay O. Epidemiological analysis of pneumococcal serotype 19A among healthy children following PCV7 vaccination. Epidemiol Infect. 2016;144:1563–73.
   PubMed Web of Science ®Google Scholar
• Kovács E, Sahin-Tóth J, Tóthpál A, Kristóf K, van der Linden M, Tirczka T, Dobay O. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: comparison of carried and clinical pneumococcal isolates from the same time period in Hungary. Vaccine. 2019;37:99–108. doi:10.1016/j.vaccine.2018.11.026.
   PubMed Web of Science ®Google Scholar
• Lindstrand A, Galanis I, Darenberg J, Morfeldt E, Naucler P, Blennow M, Alfvén T, Henriques-Normark B, Örtqvist Å. Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden. Vaccine. 2016;34:4565–71. doi:10.1016/j.vaccine.2016.10.045.
   PubMed Web of Science ®Google Scholar
• Gámez G, Castro A, Gómez-Mejia A, Gallego M, Bedoya A, Camargo M, Hammerschmidt S. The variome of pneumococcal virulence factors and regulators. BMC Genomics. 2018;19:10. doi:10.1186/s12864-017-4376-0.
   PubMed Web of Science ®Google Scholar
• Trzciński K, Li Y, Weinberger DM, Thompson CM, Cordy D, Bessolo A, Malley R, Lipsitch M. Effect of serotype on pneumococcal competition in a mouse colonization model. MBio. 2015;6(5):e00902–15. doi:10.1128/mBio.00902-15.
   PubMed Web of Science ®Google Scholar
• US patent: United States Patent Application. Immunogenic compositions comprising conjugeted capsular saccharide antigens and uses thereof; 2015. http://patents.com/us-20150202309.html
   Google Scholar
• Darrieux M, Goulart C, Briles D, Leite LC. Current status and perspectives on protein-based pneumococcal vaccines. Crit Rev Microbiol. 2015;41(2):190–200. doi:10.3109/1040841X.2013.813902.
   PubMed Web of Science ®Google Scholar
• Lu YJ, Yadav P, Clements JD, Forte S, Srivastava A, Thompson CM, Seid R, Look J, Alderson M, Tate A, et al. Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine. Clin Vaccine Immunol. 2010;17:1005–12. doi:10.1128/CVI.00036-10.
   PubMed Web of Science ®Google Scholar
• Rosch JW, Iverson AR, Humann J, Mann B, Gao G, Vogel P, Mina M, Murrah KA, Perez AC, Swords WE, et al. A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media. EMBO Mol Med. 2014;6:141–54. doi:10.1002/emmm.v6.1.
   PubMed Web of Science ®Google Scholar
• McDaniel LS, Swiatlo E. Should pneumococcal vaccines eliminate nasopharyngeal colonization? mBio. 2016;7(3):e00545–16. doi:10.1128/mBio.00545-16.
   PubMed Web of Science ®Google Scholar
• Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Rev Nat Rev Microbiol. 2018;16(6):355–67. doi:10.1038/s41579-018-0001-8.
   PubMed Web of Science ®Google Scholar
• Oikawa J, Ishiwada N, Takahashi Y, Hishiki H, Nagasawa K, Takahashi S, Watanabe M, Chang B, Kohno Y. Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan. J Infect Chemother. 2014;20:146–49. doi:10.1016/j.jiac.2013.10.007.
   PubMed Web of Science ®Google Scholar
• Spijkerman J, Prevaes SMPJ, van Gils EJM, Veenhoven RH, Bruin JP, Bogaert D, Wijmenga-Monsuur AJ, van den Dobbelsteen GP, Sanders EA. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One. 2012;7(6):e39730. doi:10.1371/journal.pone.0039730.
   PubMed Web of Science ®Google Scholar
• Bosch ATM, van Houten MA, Bruinc JP, Wijmenga-Monsuur AJ, Trzciński K, Bogaert D, Rots NY, Sanders EAM. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands. Vaccine. 2016;34:531–39. doi:10.1016/j.vaccine.2016.10.045.
   PubMed Web of Science ®Google Scholar